Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Valeritas Holdings Inc (VLRX)

Valeritas Holdings Inc (VLRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,167
  • Shares Outstanding, K 5,309
  • Annual Sales, $ 26,400 K
  • Annual Income, $ -45,930 K
  • 60-Month Beta 1.89
  • Price/Sales 0.27
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -2.38
  • Number of Estimates 1
  • High Estimate -2.38
  • Low Estimate -2.38
  • Prior Year -9.80
  • Growth Rate Est. (year over year) +75.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.10 +22.73%
on 10/14/19
1.70 -20.59%
on 09/24/19
-0.31 (-18.67%)
since 09/18/19
3-Month
1.10 +22.73%
on 10/14/19
3.04 -55.59%
on 08/08/19
-1.35 (-50.00%)
since 07/18/19
52-Week
1.10 +22.73%
on 10/14/19
26.80 -94.96%
on 10/19/18
-23.05 (-94.47%)
since 10/18/18

Most Recent Stories

More News
Valeritas Presents Positive h-Patch(TM) Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer's Disease & Dementia

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced positive data...

VLRX : 1.35 (unch)
Valeritas Announces Poster Presentation of Preclinical h-Patch(TM) Cannabidiol (CBD) Study at the American Epilepsy Society's Annual Meeting

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced today a poster...

VLRX : 1.35 (unch)
Valeritas Announces Poster Presentation of Preclinical h-Patch(TM) Apomorphine Study at the World Congress of Neurology (WCN 2019)

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced today a poster...

VLRX : 1.35 (unch)
Valeritas Hosts Educational Symposium and Participates in the Metabolic & Endocrine Disease Summit (MEDS) East

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced today it will...

VLRX : 1.35 (unch)
Valeritas Reduces its Long-Term Debt Obligation Nearly 60% by Exchanging $25.0 Million of Debt for Series B Convertible Preferred Stock

- Debt Exchange Expected to Save Approximately $8 Million in Cash Interest Expense -

VLRX : 1.35 (unch)
Medtronic's All Business Lines Grow Despite Cost Concerns

Within Diabetes group, Medtronic (MDT) is seeing a strong adoption of the Guardian Connect Smart CGM system.

MDT : 108.12 (-0.36%)
GWPH : 118.11 (-0.85%)
VLRX : 1.35 (unch)
NTRP : 0.68 (+3.02%)
Boston Scientific (BSX) Upbeat on Results of EVOLVE Study

Boston Scientific (BSX) is hopeful about robust data outcome on DAPT study as the therapy duration might prove to be a superior treatment option.

GWPH : 118.11 (-0.85%)
BSX : 38.47 (+0.79%)
NTRP : 0.68 (+3.02%)
VLRX : 1.35 (unch)
Haemonetics Grows on Strong Plasma, Hemostasis Management

Haemonetics (HAE) is gaining traction from a steady progress in Plasma franchise.

HAE : 127.25 (+0.09%)
BAX : 87.99 (+0.16%)
AMED : 135.26 (+0.46%)
VLRX : 1.35 (unch)
NuVasive Announces Innovations in Robotics Spine Surgery Line

NuVasive (NUVA) aims to speed up the adoption of less invasive spine surgery through robotics.

GWPH : 118.11 (-0.85%)
NUVA : 66.53 (+1.90%)
NTRP : 0.68 (+3.02%)
VLRX : 1.35 (unch)
Valeritas Announces Participation on "The Cutting Edge of Cannabinoid Science" Panel at the CBD Expo EAST Conference

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced today that Dr....

VLRX : 1.35 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade VLRX with:

Business Summary

Valeritas Holdings Inc. is a commercial-stage medical technology company which focused on developing technologies for Type 2 diabetes. The company's product pipeline consists of V-Go (R) Disposable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery solution for Type 2 diabetes...

See More

Key Turning Points

2nd Resistance Point 1.41
1st Resistance Point 1.38
Last Price 1.35
1st Support Level 1.29
2nd Support Level 1.23

See More

52-Week High 26.80
Fibonacci 61.8% 16.98
Fibonacci 50% 13.95
Fibonacci 38.2% 10.92
Last Price 1.35
52-Week Low 1.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar